Business Context and Reporting Period
This Form 6-K filing by Farmmi, Inc. covers the month of November 2024. The registrant is a Cayman Islands company with principal executive offices in Lishui, Zhejiang Province, China. The report details recent corporate restructuring and the formation of new subsidiaries to expand operations in the United States and China.
Key Financial Metrics
The filing text does not provide specific financial data, including revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on corporate structural changes.
Material Changes and Corporate Actions
- Formation of Suppchains Group Inc: In July 2024, Farmmi USA Inc. (a wholly-owned subsidiary) formed Suppchains Group Inc. Farmmi USA owns 75% of Suppchains, while Ttone Trucking Inc., owned by unrelated third party Hui Xu, owns the remaining 25%.
- Establishment of Suppchains Transport Inc: In October 2024, Suppchains formed a wholly-owned subsidiary, Suppchains Transport Inc., to conduct warehousing and logistics services supporting the Company's U.S. operational expansion.
- Creation of Zhejiang Famimi Biotechnology Co., Ltd: On November 4, 2024, the Company formed a new subsidiary in Lishui, China. Ownership is split between Zhejiang Suyuan Agricultural Technology Co., Ltd (95%) and Lishui Farmmi E-Commerce Co. Ltd (5%). This entity will focus on agricultural product export trading, specifically edible fungi.
Guidance, Outlook, and Risks
The filing does not contain forward-looking financial guidance, management commentary on market conditions, or specific risk factors. The stated strategic outlook involves expanding warehousing and logistics capabilities in the U.S. and enhancing agricultural export trading in China.
Key Facts for Investor Verification
- Verify the operational status and capitalization of the new 75%-owned U.S. subsidiary, Suppchains Group Inc.
- Confirm the role and financial impact of the unrelated third-party partner, Hui Xu, in the Suppchains venture.
- Assess the strategic rationale and projected revenue contribution of the new Zhejiang Famimi Biotechnology Co., Ltd. export trading subsidiary.
- Note that no financial performance data is included in this specific filing; refer to recent Form 20-F or quarterly reports for financial metrics.